Tango Therapeutics, Inc. signed a purchase agreement to issue 13,196,671 shares at a price of $5.15 per share for the gross proceeds of $67.962856 million and pre-funded warrants at a price of $5.1499 per warrant for the gross proceeds of $12.037144 million for the total gross proceeds of $80 million on August 10, 2023. The pre-funded warrants will have an exercise price of $0.0001 per share of Common stock. The transaction is expected to close on August 11, 2023.

The Private Placement is exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the ?Securities Act?) and Rule 506(b) of Regulation D.